Hoth Therapeutics Inc (HOTH) Stock Analysis

Hoth Therapeutics Inc (HOTH) is a publicly traded company in the HEALTHCARE sector. It trades at $1.34. This page summarizes the public market data, fundamentals, and frequently asked questions for HOTH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.34

Market Sentiment

Hoth Therapeutics Inc currently has a Bullish sentiment score of 0.27.

About Hoth Therapeutics Inc

Hoth Therapeutics Inc. is a biopharmaceutical company based in New York that specializes in developing innovative therapies for dermatological conditions. With a pipeline that targets unmet medical needs, Hoth aims to provide advanced treatment options for patients suffering from skin diseases. The company's commitment to research and development, combined with a strategic approach to partnerships and collaborations, positions it to make significant contributions to the dermatology sector. As...

GNG Research Analysis

GNG Research scores Hoth Therapeutics Inc (HOTH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HOTH.

Frequently Asked Questions

Does HOTH pay dividends?

Hoth Therapeutics Inc (HOTH) does not currently pay a regular dividend.